CurrentCardio
Get Weekly

Topic · page 40 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,561–1,600 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Eur J Prev Cardiol

    Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study

    Cross-sectional study

  2. Eur J Heart Fail

    Diuretic Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial

    Secondary analysis

  3. Eur J Heart Fail

    Weight Telemonitoring of Heart Failure Versus Standard of Care in a Real-World Setting: Results on Mortality and Hospitalizations in a 6-Month Nationwide Matched Cohort Study

    Cohort study

  4. Eur Heart J

    Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

    Secondary analysis

  5. Eur J Heart Fail

    Blood Pressure and Intensive Treatment Up-Titration After Acute Heart Failure Hospitalization: Insights from the STRONG-HF Trial

    Secondary analysis

  6. Eur J Heart Fail

    Carbohydrate Antigen 125 Concentrations Across the Ejection Fraction Spectrum in Chronic Heart Failure: The EMPEROR Programme

    Secondary analysis

  7. Eur J Heart Fail

    Effect of Long-Term Tafamidis Treatment on Health-Related Quality of Life in Patients with Transthyretin Amyloid Cardiomyopathy

    Secondary analysis

  8. Eur J Heart Fail

    Empagliflozin and Risk of Lower Respiratory Tract Infection in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: An EMPEROR-Preserved Analysis

    Secondary analysis

  9. Eur Heart J

    Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

    Cohort study

  10. Eur J Prev Cardiol

    Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies

    Cohort study

  11. JAMA Cardiol

    Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial

    Secondary analysis

  12. JAMA Cardiol

    Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF Score

    Diagnostic or prognostic study

  13. JACC Heart Fail

    Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up: Clinical Profiling and Mortality

    Cohort study

  14. JACC Heart Fail

    Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial

    Randomised controlled trial

  15. J Am Coll Cardiol

    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies

    Cohort study

  16. JACC Heart Fail

    Prenatal Exposure to Severe Stress and the Risk of Heart Failure Up to Middle-Age

    Cohort study

  17. JACC Heart Fail

    Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin

    Secondary analysis

  18. J Am Coll Cardiol

    Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography

    Cohort study

  19. Europace

    Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy

    Cohort study

  20. J Am Coll Cardiol

    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury

    Cohort study

  21. Eur J Heart Fail

    Clinical Implications of Subclinical Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Study

    Secondary analysis

  22. JACC Heart Fail

    Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction

    Secondary analysis

  23. Circulation

    Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy

    Cohort study

  24. Circulation

    Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling

    Diagnostic or prognostic study

  25. Eur J Heart Fail

    Distinguishing Heart Failure with Reduced Ejection Fraction from Heart Failure with Preserved Ejection Fraction: A Phenomics Approach

    Cross-sectional study

  26. Europace

    Area-weighted unipolar voltage to predict heart failure outcomes in patients with ischaemic cardiomyopathy and ventricular tachycardia

    Diagnostic or prognostic study

  27. JAMA Cardiol

    Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial

    Secondary analysis

  28. Eur J Heart Fail

    Effect of a Transitional Care Model Following Hospitalization for Heart Failure: 3-Year Outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) Randomized Controlled Trial

    Randomised controlled trial

  29. JAMA Cardiol

    Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial

    Randomised controlled trial

  30. JAMA Cardiol

    Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial

    Secondary analysis

  31. JAMA Cardiol

    Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial

    Secondary analysis

  32. Eur J Heart Fail

    Association Between Secondhand Smoke Exposure and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA)

    Cohort study

  33. Europace

    Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy

    Cohort study

  34. Eur J Heart Fail

    Deep Phenotyping of p.(V142I)-Associated Variant Transthyretin Amyloid Cardiomyopathy: Distinct from Wild-Type Transthyretin Amyloidosis?

    Cohort study

  35. Eur J Heart Fail

    Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

    Guideline or statement

  36. Eur J Heart Fail

    Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale and Design of the HF-REVERT Trial

    Trial design

  37. Eur J Heart Fail

    Blood Pressure Levels and Adverse Cardiovascular Outcomes in Heart Failure: A Systematic Review and Meta-Analysis

    Meta-analysis

  38. JACC Heart Fail

    Incidence, Outcomes, and Opportunity for Left Ventricular Assist Device Weaning for Myocardial Recovery

    Cohort study

  39. JACC Heart Fail

    Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial

    Cohort study

  40. Circulation

    Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,561–1,600 of 1,928, newest first